Robb Gary Charles

Insider profile

Performance

Overall performance
3.7

Performance over holding periods
3.7
30 days 90 days 120 days
Average return 5% 8.2% 15.1%
Success rate 61% 68% 82%
Transactions
20 0% Buy
34 71% Buy
47 69% Buy
Robb Gary Charles's trades of Corcept Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-08-26 2025-08-22 S Sale
51,180 +8.6%
447.29
US$1,239,468
51,180 +8.6% 447.29 US$1,239,468
2025-08-22 2025-08-22 PrS Proposed sale
85,585
39.06
US$1,021,548
85,585 39.06 US$1,021,548
2025-06-18 2025-06-16 S Sale
56,046 +35.1%
170.99
US$616,730
56,046 +35.1% 170.99 US$616,730
2025-06-16 2025-06-16 PrS Proposed sale
3,185
70.77
US$225,402
3,185 70.77 US$225,402
2025-05-22 2025-05-20 S Sale
2,279 -12.1%
75.85
US$172,862
2,279 -12.1% 75.85 US$172,862
2025-05-20 2025-05-20 PrS Proposed sale
2,279
75.85
US$172,862
2,279 75.85 US$172,862
2025-01-06 2025-01-02 PlS Planned sale
11,000 -35.3%
50.50
US$555,552
11,000 -35.3% 50.50 US$555,552
2025-01-02 2025-01-02 PrS Proposed sale
11,000
50.45
US$554,986
11,000 50.45 US$554,986
2024-11-26 2024-11-22 S Sale
2,609 -11.5%
56.20
US$146,626
2,609 -11.5% 56.20 US$146,626
2024-11-22 2024-11-22 PrS Proposed sale
2,609
56.20
US$146,626
2,609 56.20 US$146,626
2024-10-01 2024-10-01 PrS Proposed sale
11,000
46.28
US$509,080
11,000 46.28 US$509,080
2024-10-01 2024-10-01 PlS Planned sale
11,000 -32.6%
46.28
US$509,080
11,000 -32.6% 46.28 US$509,080
2024-08-28 2024-08-26 S Sale
3,101 -11.8%
35.71
US$110,737
3,101 -11.8% 35.71 US$110,737
2024-08-26 2024-08-26 PrS Proposed sale
3,101
35.71
US$110,737
3,101 35.71 US$110,737
2024-07-03 2024-07-01 PlS Planned sale
11,000 -29.5%
32.49
US$357,390
11,000 -29.5% 32.49 US$357,390
2024-07-01 2024-07-01 PrS Proposed sale
11,000
32.49
US$357,390
11,000 32.49 US$357,390
2024-05-30 2024-05-28 PlS Planned sale
11,000 -35.3%
30.39
US$334,294
11,000 -35.3% 30.39 US$334,294
2024-05-28 2024-05-28 PrS Proposed sale
11,000
27.52
US$302,720
11,000 27.52 US$302,720
2023-12-06 2023-12-06 PrS Proposed sale
6,212
26.46
US$164,370
6,212 26.46 US$164,370
2023-12-06 2023-12-06 S Sale
6,212 -22.5%
27.01
US$167,786
6,212 -22.5% 27.01 US$167,786
2023-12-06 2023-12-05 S Sale
1,381 -4.8%
26.27
US$36,277
1,381 -4.8% 26.27 US$36,277
2023-12-05 2023-12-05 PrS Proposed sale
1,381
26.26
US$36,265
1,381 26.26 US$36,265
2023-09-20 2023-09-19 S Sale
5,000 -18.5%
32.74
US$163,677
5,000 -18.5% 32.74 US$163,677
2023-09-19 2023-09-19 PrS Proposed sale
5,000
32.32
US$161,600
5,000 32.32 US$161,600
2023-05-11 2023-05-10 S Sale
14,000 -41.2%
24.07
US$336,980
14,000 -41.2% 24.07 US$336,980
2023-05-11 2023-05-09 S Sale
30,000 -46.9%
23.87
US$716,100
30,000 -46.9% 23.87 US$716,100
2023-05-09 2023-05-09 PrS Proposed sale
44,414
23.76
US$1,055,277
44,414 23.76 US$1,055,277
2022-11-23 2022-11-23 S Sale
186 -0.9%
26.03
US$4,842
186 -0.9% 26.03 US$4,842
2022-11-23 2022-11-22 S Sale
4,814 -18.4%
26.03
US$125,308
4,814 -18.4% 26.03 US$125,308
2022-11-21 2022-11-18 S Sale
13,401 -33.9%
26.43
US$354,188
13,401 -33.9% 26.43 US$354,188
2022-11-21 2022-11-17 S Sale
10,000 -20.2%
26.06
US$260,600
10,000 -20.2% 26.06 US$260,600
2022-09-08 2022-09-07 S Sale
50,000 -50.2%
26.06
US$1,303,000
50,000 -50.2% 26.06 US$1,303,000
2022-07-08 2022-07-06 PlS Planned sale
45,000 -65.1%
26.00
US$1,170,000
45,000 -65.1% 26.00 US$1,170,000
2022-05-19 2022-05-19 S Sale
6,127 -14.4%
19.57
US$119,928
6,127 -14.4% 19.57 US$119,928
2022-05-19 2022-05-18 S Sale
128 -0.3%
19.55
US$2,502
128 -0.3% 19.55 US$2,502
2022-05-19 2022-05-17 S Sale
28,745 -40.2%
19.55
US$561,965
28,745 -40.2% 19.55 US$561,965
2022-03-18 2022-03-18 PlS Planned sale
4,988 -6.5%
24.67
US$123,054
4,988 -6.5% 24.67 US$123,054
2022-03-18 2022-03-17 PlS Planned sale
7,512 -8.9%
24.68
US$185,374
7,512 -8.9% 24.68 US$185,374
2021-02-16 2021-02-12 S Sale
112,100 -56.7%
28.22
US$3,163,899
112,100 -56.7% 28.22 US$3,163,899
2021-02-16 2021-02-11 S Sale
3,400 -1.7%
29.78
US$101,249
3,400 -1.7% 29.78 US$101,249